[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations65593826
h-index2721
i10-index19588

..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE

..
:: Volume 30, Issue 1 (3-2022) ::
Journal of Ilam University of Medical Sciences 2022, 30(1): 55-64 Back to browse issues page
Evaluation of mRNA Expression of Calcitonin Gene-Dependent Peptide (CGRP) and Rat Calcitonin (rCT) in the Periaqueductal Gray Area (PAG) of Diabetic Rats in the Formalin Test
Olya Moshiri1 , Javad Sajedianfard * 2, Saeid Hosseinzadeh3 , Kaveh Rahimi1 , Saeedeh Ahmadi Jokani1
1- Dept of Basic Sciences, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran
2- Dept of Basic Sciences, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran , sajedian@shirazu.ac.ir
3- Dept of Food Hygiene, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran
Abstract:   (1225 Views)
Introduction: CGRP and rCT are involved in descending pain control areas. This study aimed to evaluate the effect of intracerebroventricular administration (ICV) of CGRP and rCT on mRNA expression of CGRP and rCT peptides in the Periaqueductal Gray Area (PAG) of the diabetic rats in the formalin test.
Material & Methods: This study investigated 24 male Sprague-Dawley rats in four groups (n=6). To induce diabetes, streptozotocin at a dose of 45 mg/kg was used intraperitoneally. CGRP or rCT peptides at a dose of 1.5 nmol with a volume of 5 μl were ICV injected daily for seven days. Pain-related behaviors were recorded in the formalin test for up to 60 min in the study groups. The PAG was then removed to assess the changes made in the mRNA expression of the CGRP and rCT.
(Ethic code: INT2M129396)
Findings: ICV injection of CGRP or rCT in diabetic rats reduced pain in the acute and middle phases of the formalin test. In addition, ICV administration of CGRP increased CGRP mRNA expression in the PAG. However, ICV administration of rCT increased the mRNA expression of both CGRP and rCT peptides after seven days in the PAG.
Discussion & Conclusion: ICV injection of CGRP and rCT peptides reduced the pain of formalin injection in rats in the experimental model of streptozotocin-induced diabetes mellitus, possibly by altering the mRNA expression of both peptides.
 
Keywords: Analgesia, CGRP, Diabetes, mRNA, rCT
Full-Text [PDF 1603 kb]   (524 Downloads)    
Type of Study: Research | Subject: physiology
Received: 2021/06/3 | Accepted: 2021/10/27 | Published: 2023/03/6
References
1. Cannon JT, Prieto GJ, Lee A,Liebeskind JC. Evidence for opioid and non-opioid forms of stimulation –produced analgesia in the rat. Brain Res. 1982; 243:2:315-21. doi: 10.1016/0006-8993:8290255-4
2. Mason P. Medullary circuits for nociceptive modulation. Curr Opin Neurobiol. 2012; 22:4:640- doi: 10.1016/j.conb.2012.03.008.
3. Pozo-Rosich P, Storer RJ, Charbit AR, Goadsby PJ. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons. Cephalalgia: IHS. 2015; 35:14:1298-307. doi:10.1177/0333102415576723.
4. Huang Y, Brodda-Jansen G, Lundeberg T, Yu LC. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone. Brain. 2000; 873:1:54-9.doi: 10.1016/s0006-8993(00)02473-2.
5. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, et al. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. JCI. 1992; 90:5:1726-35. doi: 10.1172/JCI116046.
6. Pecile A, Guidobono F, Netti C, Sibilia V, Biella G, Braga PC. Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin. Regul Pept. 1987;18:3-4:189-99. doi: 10.1016/0167-0115(87)90007-3.
7. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1(Suppl 1):S62-S9. doi: 10.2337/dc10-S062
8. Balali Dehkordi Sh, Sajedianfard J, Owji AA. The effect of intra-cerebroventricular injection of insulin on the levels of monoamines on the raphe magnus nucleus of non-diabetic and short-term diabetic rats in the formalin test. Iran J Basic Med Sci. 2019; 22:8: 915–921. doi: 10.22038/ijbms.2019.35580.8485.
9. Walker CS, Conner AC, Poyner DR, Hay DL. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci. 2010; 31:10:476-83. doi: 10.1016/j.tips.2010.06.006 .
10. Yu L-C, Weng X-H, Wang J-W, Lundeberg T. Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats. Neurosci Lett. 2003;349:1:1-4. doi: 10.1016/S0304-3940(03)00273-8.
11. Eftekhari S, Edvinsson L. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neuroscience. 2011;4:8:43-52. doi: 10.1186/1471-2202-12-112.
12. Poyner DR. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther. 1992; 56:1:23-51. doi: 10.1016/0163-7258(92)90036-y .
13. Harmann PA, Chung K, Briner RP, Westlund KN, Carlton SM. Calcitonin gene-related peptide (CGRP) in the human spinal cord: a light and electron microscopic analysis. J. Comp. Neurol. 1988; 269:3:371-80. doi: 10.1002/cne.902690305.
14. Rahimi K, Sajedianfard J, Owji A.A. The effect of intracerebroventricular injection of CGRP on pain behavioral responses and monoamines concentrations in the periaqueductal gray area in rat. IJBMS. 2018:21:4:395-399. doi: 10.22038/IJBMS.2018.26384.6467.
15. Gibson SJ, Polak JM, Bloom SR, Sabate IM, Mulderry PM, Ghatei MA, McGregor GP, Morrison JF, Kelly JS, Evans RM. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. JNeurosci. 1984;4:12::3101-1. doi: 10.1523/JNEUROSCI.04-12-03101.1984.
16. Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain. 2017;158:4:543-559. doi: 10.1097/j.pain.0000000000000831
17. Bhatt DK, Gupta S, Ploug KB, Jansen-Olesen I, Olesen J. mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC. Neurosci Lett. 2014; 24 :559:99-104. doi: 10.1016/j.neulet.2013.11.057 .
18. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad. Sci. U.S.A. 2007; 104:76: 13525–13530. doi: 10.1073/pnas.0705924104 .
19. Macpherson LJ, Xiao B, Kwan KY, Petrus MJ, Dubin AE, et al. An ion channel essential for sensing chemical damage. J Neurosci. 2007; 27: 11412–11415. doi: 10.1523/JNEUROSCI.3600-07.
20. White S, Marquez de Prado B, Russo A.F. Hammond D.L. Heat Hyperalgesia and Mechanical Hypersensitivity Induced by Calcitonin Gene-Related Peptide in a Mouse Model of Neurofibromatosis. PLos One. 2014;9:9:1-10. doi: 10.1371/journal.pone.0106767.
21. Spampinato S, Candeletti S, Cavicchini E, Romualdi P, Speroni E, Ferri S. Antinociceptive activity of salmon calcitonin injected intrathecally in the rat. Neurosci Lett. 1984;45(2):135-9. doi.org/10.1016/0304-3940(84)90088-0.
22. Zou Y, Xu F, Tang Z, Zhong T, Cao J, Guo Q, et al. Distinct calcitonin gene-related peptide expression pattern in primary afferents contribute to different neuropathic symptoms following chronic constriction or crush injuries to the rat sciatic nerve. Mol pain. 2016;12:1744806916681566. doi: 10.1177/1744806916681566.
23. Daneshyar S, Gharakhanlou R, Nikooie R, Forutan Y. The effect of high-fat diet and streptozotocin-induced diabetes and endurance training on plasma levels of calcitonin gene-related peptide and lactate in rats. CanJDiabetes. 2014;38: 461-465. doi: 10.1016/j.jcjd.2014.03.001.
24. Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015;6:3:432-44. doi: 10.4239/wjd.v6.i3.432.
25. Lee JH, McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain. 1992;50:2:231-6. doi. 10.1016/0304-3959(92)90167-A.
26. Li H, Song Y, Wang Z, Wu Y, Wang W, Han J. Overexpression of CGRP improves peripheral neuropathy in diabetic mice. Chinese. 2019; 35:3:250-255.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: 96INT2M1293



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moshiri O, Sajedianfard J, Hosseinzadeh S, Rahimi K, Ahmadi Jokani S. Evaluation of mRNA Expression of Calcitonin Gene-Dependent Peptide (CGRP) and Rat Calcitonin (rCT) in the Periaqueductal Gray Area (PAG) of Diabetic Rats in the Formalin Test. J. Ilam Uni. Med. Sci. 2022; 30 (1) :55-64
URL: http://sjimu.medilam.ac.ir/article-1-7125-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 30, Issue 1 (3-2022) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.15 seconds with 41 queries by YEKTAWEB 4657